- Home
- SOS vs OSRH Comparison
SOS vs OSRH Comparison
Compare SOS & OSRH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | SOS | OSRH |
|---|---|---|
| Founded | 2004 | N/A |
| Country | China | United States |
| Employees | N/A | 21 |
| Industry | Finance: Consumer Services | |
| Sector | Finance | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.7M | 11.7M |
| IPO Year | 2005 | N/A |
Fundamental Metrics
Financial Performance| Metric | SOS | OSRH |
|---|---|---|
| Price | $1.22 | $0.59 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 63.0K | ★ 715.1K |
| Earning Date | 05-14-2026 | 05-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $9.30 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.90 | $0.38 |
| 52 Week High | $8.92 | $1.79 |
Technical Indicators
Market Signals| Indicator | SOS | OSRH |
|---|---|---|
| Relative Strength Index (RSI) | 55.41 | 62.18 |
| Support Level | $1.15 | $0.54 |
| Resistance Level | $1.56 | $0.60 |
| Average True Range (ATR) | 0.13 | 0.05 |
| MACD | 0.04 | 0.01 |
| Stochastic Oscillator | 71.11 | 80.51 |
Price Performance
Historical ComparisonAbout SOS SOS Limited
SOS Ltd is a multifaceted company that leverages the power of data to provide marketing solutions, while also participating in the burgeoning fields of blockchain and cryptocurrency operations, as well as commodity trading. Its product offerings are diversified across four main areas: commodity trading, insurance marketing, cryptocurrency mining, and other services. The company has three reporting segments: Commodity trading, Cryptocurrency mining, and Others. Key revenue is generated from Commodity trading.
About OSRH OSR Holdings Inc.
OSR Holdings Inc is a healthcare company dedicated to healthcare outcomes and improving the quality of life for people and their families. It builds and develops a robust portfolio of potentially transformative therapies and healthcare solutions. The business of the company includes developing oral immunotherapies for the treatment of cancer, developing design-augmented biologics for age-related and other degenerative diseases, and neurovascular intervention medical device and systems distribution in Korea.